HomeOpen Access NewsPharmaceutical Industry

Pharmaceutical Industry

NPA analysis finds over 6 million hours spent in A&E on cases treatable by community pharmacies

A new report by the National Pharmacy Association reveals that patients spent over 6 million hours in A&E last year for minor health issues that could have been managed by community pharmacies, highlighting an opportunity to ease pressure on emergency services.

Addressing gaps in systemic lupus erythematosus management

Lupus is on the rise, yet awareness of the disease remains relatively low. However, efforts are underway to tackle existing gaps in managing the condition, as we discover here.

MASTERPLANS to disentangle Systemic Lupus Erythematosus (SLE)

Professor Ian N Bruce MD FRCP, Professor of Rheumatology at the University of Manchester shares his expertise here on Systemic Lupus Erythematosus (SLE), a chronic multisystem autoimmune condition.

UK and Ireland medical cannabis access programmes and education slowly progress

GreenLight Pharmaceuticals Ltd is advancing clinical research and education in UK and Ireland; Though government progress on access and prescribing recommendations lags behind much of Europe.

Ugandan President to explore use of MediConnect to tackle counterfeit drugs

MediConnect is pleased to announce that it has received indicative support from the Ugandan government to explore the use of its solution to tackle the spread of counterfeit drugs.

NHS to trial ‘subscription’ payment model for pharmaceutical companies

The NHS will test the world's first ‘subscription’ style payment model to incentivise pharmaceutical companies to develop new drugs for resistant infections.

Pharmacy and EPMA solution provider JAC renamed as WellSky

UK, JAC Computer Services Ltd has announced it has renamed as WellSky International Ltd.

Artificial Intelligence in diagnostic medicine – a tool to replace clinicians?

Here, Gerry Morrow discusses whether we will ever see AI fully replicate autonomous decision making and what the future role of AI in diagnostic medicine is.

Five-year license issued to “Pharma Essenza Cannabis SA” and “PENTE SA”

A five-year license has been issued to two companies allowing the cultivation and processing of medical cannabis products.

Nano DDS technology contributes to next-generation cancer immunotherapy

Dr Takashi Nakamura from Hokkaido University challenges the potential of nano-tech based drug delivery system (Nano DDS) in the development of next-generation cancer immunotherapy.

Addressing skills shortages critical to the future of UK science

The UK must address the increasing number of science skills shortages to maintain its world-leading position for medicines and vaccines research and development, says the Association of the British Pharmaceutical Industry (ABPI).

Young men with anxiety in need of more support

Research reveals that 70% of young men with anxiety report that their work performance and relationships are affected, yet well over half of them are still not seeking help.

Cutting-edge technology synergy in the personalised nanomedicine space: Focus on pharmaceutical nanomanufacturing

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group explains cutting-edge technology synergy in the personalised nanomedicine space, with a special focus on pharmaceutical nanomanufacturing

From molecule to medicine

A report this week from the Office of Health Economics (OHE) shows the amazing impact medicines have had on the NHS and more widely

Chemistry in the UK today

Open Access Government explores the exciting world of chemistry in the UK today, including heterocycles in pharmaceuticals and the importance of inspiring the next generation to work in the field

Mental health care and the pharmaceutical industry

Marcin Rodzinka, Project Coordinator at Mental Health Europe explains how transparency between the pharma industry and health professionals can influence the quality of mental health care in Europe today

Medical and pharmaceutical statistics research: Professional development courses

Prof Thomas Jaki from the Medical and Pharmaceutical Statistics Research Unit at Lancaster University provides an overview of the professional development courses offered at the unit

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders